Robert C. Young, M.D., Appointed Chancellor at Fox Chase Cancer Center
PHILADELPHIA (June 13, 2007) — Robert C. Young, MD, of Chestnut Hill, Pa., has been appointed chancellor at Fox Chase Cancer Center, a position he assumed on June 1 after serving as the Center's president and CEO for 18 years.
In announcing Young's new role, Fox Chase president and CEO Michael V. Seiden, MD, PhD, said, "The creation of this new position reflects my confidence that Dr. Young's experience and energy will be important in leading a variety of local, regional, and national initiatives important to our Cancer Center as well as the National Cancer Institute."
Reporting to the president and working with the board of directors and senior leadership, Young will lead several efforts including serving as the chairman of the Board of Scientific Advisors of the National Cancer Institute and advocating for the Fox Chase Cancer Center both at the national and state levels. Young will also continue to work with institutional leaders in the completion of the Cancer Research Pavilion and expansion projects as well continuing to work with donors and members of the institutional advancement team to complete the Center's Centennial Campaign.
"Fox Chase Cancer Center is fortunate to have retained Dr. Young who will continue to contribute to the Center," said Seiden.
Young announced his plans to step down as Fox Chase's president last September. His legacy includes the first comprehensive program of cancer prevention research, the Research Institute for Cancer Prevention. Later this month, the Cancer Prevention Pavilion, which opened in January 2000, will be named the Robert C. Young, MD, Pavilion for Cancer Research in his honor.
In addition, board member Margot Wallace Keith and her husband, Robert E. Keith Jr., of Newtown Square, Pa., will endow a new $1.5 million chair in Young's honor. Margot Keith, who has been active in several area arts and civic organizations, joined the Fox Chase board in 2001. Robert Keith is the managing general partner, president and CEO of TL Ventures and is also board chairman of Safeguard Scientifics and the Internet Capital Group, Inc. The Robert C. Young, MD, Endowed Chair in Cancer Research will help stimulate innovative research leading to novel treatments, diagnostic and prevention techniques, the Keiths said.
Young is internationally known for his work in the treatment of lymphoma and ovarian cancer. He became president of Fox Chase in December 1988 after serving as chief of NCI's medicine branch and associate director of the NCI cancer centers and community oncology program. He is a past-president of the American Cancer Society, the American Society of Clinical Oncology (ASCO), and the International Gynecologic Cancer Society.
He received ASCO's Distinguished Service Award for Scientific Leadership in 2004 and was co-recipient of the 2002 Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research for his research in ovarian cancer.
Young recently completed his appointment to the National Cancer Policy Board at the Institute of Medicine. A fellow of the American College of Physicians, Young is also a member of the prestigious American Society of Clinical Investigation.
Born in Columbus, Ohio, Young received his B.Sc. degree in zoology in 1960 from Ohio State University and his M.D. in 1965 from Cornell University Medical College. Following his internship at New York Hospital, he completed his residency at NCI and Yale-New Haven Medical Center. He is board-certified in internal medicine, hematology and oncology by the American Board of Internal Medicine.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.